Search the Newsreel

AZAD ENGINEERING LTD. Share Price Today Up 7%

Jazz Pharmaceuticals (JAZZ) Stock Looks Cheap On Earnings While Broader Checks Stay Mixed

Jazz Pharmaceuticals (JAZZ) stock has shown a significant return of 112.6% over the past year. Despite this performance and recent deal activity, the stock appears undervalued based on its P/E ratio of 17.2x, which is on par with the industry average but significantly lower …

A2Z Cust2Mate Solutions Corp (AZ) (Q2 2026) Earnings Call Highlights: Smart Cart Deliveries ...

This article first appeared on GuruFocus. Release Date: August 12, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Sequential revenue growth of 78% in Q2 2026, with smart cart deliveries nearly doubling to …

Amazon's Zoox Launches Paid Robotaxi Service In Las Vegas and Says 'We Need To Be Regulated'— The Smoke Incident That Prompted a Recall Explains Why

Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below. Zoox CEO Aicha Evans backed stronger federal oversight of autonomous vehicles as the Amazon.com Inc. subsidiary began charging passengers for driverless rides in Las Vegas, weeks after …

AstraZeneca Stock And 2 Cash Flow Picks Trading Below Fair Value

Corazon Mining Commences Maiden RC Drilling at Feather Cap Gold Project in Western Australia

Braze, Inc. (BRZE) CBO Astha Malik sells 33,656 shares in 10b5-1 plan trade

Braze, Inc.'s Chief Business Officer, Astha Malik, sold 33,656 shares of Class A common stock on August 10, 2026, at a weighted average price of $27.65 per share. This transaction was executed under a Rule 10b5-1 trading plan adopted on April 15, 2026. After …

A2Z Cust2Mate Solutions Corp. (AZ) Reports Q2 Loss, Beats Revenue Estimates

A2Z Cust2Mate Solutions Corp. (AZ) came out with a quarterly loss of $0.16 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.31 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, …

A2Z Cust2Mate Solutions (NASDAQ:AZ) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS

A2Z Cust2Mate Solutions (NASDAQ: AZ) triples revenue but burns cash in H1 2026

Alphabet, Amazon, Meta Platforms, and Microsoft: One of These Stocks Looks Like It Has the Least Upside Over the Next 12 Months, but There's a Catch

Among Alphabet, Amazon, Meta Platforms, and Microsoft, Microsoft appears to have the least upside potential over the next 12 months based on current analyst price targets. However, this outlook is skewed by a recent rapid surge in Microsoft's stock price following strong Q4 fiscal …

Azenta (AZTA) Is Up 11.5% After Returning To Profit And Raising Revenue Outlook - Has The Bull Case Changed?

Azenta (AZTA) recently reported a return to profitability in Q3 2026, with net income of US$2.46 million and revenue of US$161.18 million, alongside a US$50 million share repurchase. The company also raised its full-year revenue guidance to US$613-US$618 million, signaling increased confidence in its …

Amazon (AMZN) Is Powering OpenAI’s Cyber Models, So Why Is The Stock So Cheap?

Amazon (NASDAQ:AMZN) just gave security teams a fresh reason to watch its cloud business. On August 11, two specialized cybersecurity models from OpenAI, Daybreak Red and Daybreak Blue, went live on Amazon Bedrock for eligible customers, and AWS's own security teams are already using …

Is Amazon (AMZN) a Solid Growth Stock? 3 Reasons to Think "Yes"

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great growth stock is not easy at all. By their very nature, these stocks carry above-average …

Azz Pres & COO Jeffrey Vellines sells $647,981 of company stock

Jeffrey Vellines, President and COO of Precoat Metals at AZZ INC, sold 4,220 shares of company stock for a total of $647,981 on August 11, 2026. The shares were sold at an average price of $153.55. This insider sale comes as AZZ shares trade …

Amazon Raises 2026 AI Spending to $220B: Smart Bet or Riskier Trap?

Amazon has increased its 2026 capital expenditure forecast to $220 billion, primarily due to higher costs for AI and cloud infrastructure, signaling the central role of AI in its growth. This investment is supported by strong AWS revenue growth, expanding operating margins, and a …

Jazz Pharmaceuticals Bolsters Epilepsy Division With Actio Biosciences Buyout (JAZZ)

Is Beazer Homes USA (BZH) Stock Outpacing Its Construction Peers This Year?

Maze Therapeutics (NASDAQ:MAZE) Earns "Buy" Rating from BTIG Research

BTIG Research has reaffirmed its "Buy" rating for Maze Therapeutics (NASDAQ:MAZE), setting a $46 price target, indicating a potential 68.44% upside. The company has a consensus "Buy" rating from analysts with an average target price of $66, despite some insider selling totaling approximately $3.9 …

Braze CTO Jonathan Hyman sells $760k in company stock

Braze CTO Jonathan Hyman sold Class A common stock worth over $760,000 in early August through a pre-arranged trading plan. Despite the insider sales, Braze shares have shown significant recent gains, and analysts maintain a positive outlook, with several initiating or reiterating Buy ratings …

Faze Three Q1 Results: Board Approves Unaudited Standalone & Consolidated Financials

AstraZeneca slips Wednesday, underperforms market

AstraZeneca PLC (AZN) shares fell 1.20% to £117.02 on Wednesday, underperforming the broader market as the FTSE 100 Index (UKX) also dropped. The company's stock closed 25.62% below its 52-week high.

Lazard's July AUM Was ~$287B, Including $1.5B in Market Appreciation

Lazard (NYSE: LAZ) reported preliminary assets under management (AUM) of approximately $286.9 billion as of July 31, 2026, an increase from $284.7 billion at June 30, 2026. This growth was primarily driven by $1.5 billion in market appreciation, alongside $0.4 billion in net inflows …

Wedge Capital Management L L P NC Sells 33,467 Shares of Jazz Pharmaceuticals PLC $JAZZ

Wedge Capital Management L L P NC reduced its stake in Jazz Pharmaceuticals PLC by 20.9% in the second quarter, selling 33,467 shares and retaining 126,539 shares valued at approximately $30.5 million. Despite missing quarterly EPS estimates, the company's revenue exceeded expectations, and analysts …

Lazard Reports July 2026 Assets Under Management

NEW YORK, Aug. 12, 2026 /PRNewswire/ -- Lazard, Inc. (NYSE: LAZ) reported today that its preliminary assets under management ("AUM") as of July 31, 2026 totaled approximately $286.9 billion. The month's AUM included market appreciation of $1.5 billion, net inflows of $0.4 billion and …

Amazon.com, Inc. $AMZN Position Increased by Hamilton Wealth LLC

Hamilton Wealth LLC significantly increased its stake in Amazon.com, Inc. ($AMZN) by

Upbeat Earnings Forecasts and Technical Breakout Could Be A Game Changer For H World Group (HTHT)

Genesis Financial Group LLC Has $6.28 Million Position in Amazon.com, Inc. $AMZN

Genesis Financial Group LLC has significantly reduced its stake in Amazon.com, Inc. by 14.1% in the first quarter, now holding 30,162 shares valued at $6.28 million. Despite this reduction and insider stock sales totaling $20.5 million, Wall Street analysts maintain a "Moderate Buy" consensus …

Amazon Grew Revenue 20%. Here's the Only Reason I Can Think Of for Why Amazon Trades at Just 22 Times Forward Earnings.

Key Points Amazon will spend $220 billion on capital expenditures this year after spending $132 billion in 2025. The company had built a strong balance sheet, but the company's borrowing may have investors questioning its spending.10 stocks we like better than Amazon › The …

Silicon Valley Capital Partners Has $34.68 Million Position in Amazon.com, Inc. $AMZN

Silicon Valley Capital Partners reduced its stake in Amazon.com by 6.8% in Q1, now holding 166,536 shares valued at $34.68 million. Despite this, Amazon remains a significant portion of their portfolio, and institutional investors collectively own 72.2% of the stock. The company recently reported …

Maze Therapeutics, Inc. (NASDAQ:MAZE) Given Average Recommendation of "Buy" by Brokerages

Maze Therapeutics (NASDAQ:MAZE) has received an average "Buy" rating from eleven brokerages, with an average 12-month price target of $66.00, significantly higher than its current trading price of $27.31. The company recently reported quarterly earnings per share of -$0.76, meeting estimates, while analysts anticipate …

Jazz Pharmaceuticals (JAZZ) Q2 2026 Earnings Call Transcript

Three Q4 stock picks: Amazon, Las Vegas Sands, and Carnival

The article highlights three Q4 stock picks: Amazon, Las Vegas Sands, and Carnival, based on anticipated holiday spending. Amazon is presented as a compelling value stock despite its growth appearance, Las Vegas Sands as a deep value play recovering from lows, and Carnival as …

Amazon.com, Inc. $AMZN Stock Position Reduced by Cim LLC

Cim LLC decreased its stake in Amazon.com, Inc. by 6.9% during the first quarter, selling 6,617 shares and retaining 89,777 shares valued at $18.7 million. Despite this reduction, Amazon reported strong quarterly results with revenue up 19.6% year over year and earnings per share …

Centaurus Financial Inc. Purchases 6,304 Shares of Amazon.com, Inc. $AMZN

Centaurus Financial Inc. increased its stake in Amazon.com, Inc. by 3.2% in the first quarter, purchasing an additional 6,304 shares, bringing its total holdings to 202,208 shares valued at $42.1 million. This increase makes Amazon its 5th largest position, representing 2.0% of Centaurus Financial's …

Ashton Thomas Securities LLC Boosts Holdings in Amazon.com, Inc. $AMZN

Ashton Thomas Securities LLC increased its stake in Amazon.com, Inc. by 28.4% in the first quarter, now owning 49,259 shares valued at $10.26 million. This move is part of broader institutional interest, with hedge funds and other institutional investors owning 72.2% of Amazon stock. …